Research Units at the Harvard-MIT Center for Regulatory Science
The Center’s research units embody our commitment to cross-disciplinary collaboration with scientists and other subject matter experts in regulatory agencies, pharmaceutical companies, and academic institutions to produce cutting-edge research that informs regulatory decision making and policy while enhancing confidence in the safety and effectiveness of approved medical products.
Featured Research Units
Clinical Evidence and Communication Unit
This unit works to drive robust evidence generation via objective and measurable assessments of clinical trial evidence, and enhanced communication about drug benefits and FDA-compliance.
Read More
Pediatric Therapeutics and Regulatory Science Initiative
This unit seeks to review and improve the system of developing novel drugs and therapeutics for pediatric use. The initiative will inform regulatory policy, improving the safe and effective use of drugs and devices in children.
Read More
Explore More of Our Research
Interested in a specific project? Visit each unit’s dedicated page to learn more
about goals, processes, and specific outputs.